Global Viral Vector Manufacturing Services Market Report By Product (Retroviral Vectors, Adenoviral Vectors, Adeno-associated Viral Vectors, Other), By Application (Pharmaceutical and Biopharmaceutical Companies, Research Institutes) And By Regions - Industry Trends, Size, Share, Growth, Estimation and Forecast, 2021-2028

Name: Global Viral Vector Manufacturing Services Market Report
Brand: Value Market Research
SKU: Medical Devices
Price: 3950.00 USD
Availability: OnlineOnly
Rating: 4.2 (80 reviews)

ID:VMR11213138

April 2021

Report Formats: Electronic (PDF), MS EXCEL

Description
Table Of Content

The global demand for Viral Vector Manufacturing Services Market is presumed to reach the valuation of nearly USD XX MN by 2028 from USD XX MN in 2021 with a CAGR of XX% during the period of 2022-2028.

Viral vector manufacturing services include generation, production, purification, and analysis of viral vector-based products manufactured on mammalian cell lines. The services support both upstream production and downstream purification. The upstream processing includes adherent and suspension modes while that of downstream processing includes purification technology, chromatography, TFF, filtration, and others.

Market Dynamics

Continued investment in viral and gene therapies from clinical to commercial scale fuels the growth of the global viral vector manufacturing services market. Gene and cell therapies are rapidly advancing to late-stage clinical trials and commercialization. There is a growing need for flexible, high-quality advanced viral vector development and manufacturing services to provide the highest level of patient safety and reliability. Gene and cell therapy (GCT) can potentially transform medicine, providing long term and potentially curative treatment options for a wide range of diseases. Recognizing the growing need for viral vector production services on the development and commercial scale, players are expanding their capacity. However, there are a limited number of biopharmaceutical companies and contract development and manufacturing organizations (CDMOs) with the resources in place across all stages of the drug development cycle. Responding to this, companies are widening their range of offerings by adding viral vector and gene-therapy services. Alongside a growing manufacturing footprint, the company has found its services in demand during the novel coronavirus outbreak.

The report covers Porter’s Five Forces Model, Market Attractiveness Analysis and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level.

Additionally, these tools also give inclusive assessment of each application/product segment in the global market of viral vector manufacturing services.

Market Segmentation

The entire viral vector manufacturing services market has been sub-categorized into product and application. The report provides an analysis of these subsets with respect to the geographical segmentation. This research study will keep marketer informed and helps to identify the target demographics for a product or service.

By Product

Retroviral Vectors
Adenoviral Vectors
Adeno-associated Viral Vectors
Other

By Application

Pharmaceutical and Biopharmaceutical Companies
Research Institutes

Regional Analysis

This section covers regional segmentation which accentuates on current and future demand for viral vector manufacturing services market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand for individual application segment across all the prominent regions.

Global Viral Vector Manufacturing Services Market Share by Region (Representative Graph)

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the viral vector manufacturing services market include Novasep, Spark Therapeutics, Lonza Pharma & Biotech, Takara Bio, Sartorius, ABL, Inc., Fujifilm Diosynth Biotechnologies, Cobra Biologics, Sanofi, Finvector, uniQure. This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1 . PREFACE
       1.1. Report Description
           1.1.1. Objective
           1.1.2. Target Audience
           1.1.3. Unique Selling Proposition (USP) & offerings
       1.2. Research Scope
       1.3. Research Methodology
           1.3.1. Market Research Process
           1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY
       2.1. Highlights of Viral Vector Manufacturing Services Market
       2.2. Global Viral Vector Manufacturing Services Market Snapshot

3 . VIRAL VECTOR MANUFACTURING SERVICES – INDUSTRY ANALYSIS
       3.1. Introduction
       3.2. Market Drivers of Viral Vector Manufacturing Services Market
       3.3. Market Restraints of Viral Vector Manufacturing Services Market
       3.4. Opportunities of Viral Vector Manufacturing Services Market
       3.5. Trends of Viral Vector Manufacturing Services Market
       3.6. Porter’s Five Force Analysis of Viral Vector Manufacturing Services Market
       3.7. Viral Vector Manufacturing Services Market Attractiveness Analysis
           3.7.1 Market Attractive Analysis by Product
           3.7.2 Market Attractive Analysis by Application
           3.7.3 Market Attractive Analysis by Region

4 . VALUE CHAIN ANALYSIS
       4.1. Viral Vector Manufacturing Services Value Chain Analysis
       4.2. Viral Vector Manufacturing Services Raw Material Analysis
           4.2.1. List of Raw Materials
           4.2.2. Viral Vector Manufacturing Services Raw Material Manufactures List
           4.2.3. Price Trend of Viral Vector Manufacturing Services Key Raw Materials
       4.3. List of Potential Buyers
       4.4. Marketing Channel
           4.4.1. Direct Marketing
           4.4.2. Indirect Marketing
           4.4.3. Marketing Channel Development Trend

5 IMPACT ANALYSIS OF COVID-19 OUTBREAK
       5.1. Impact Analysis of Covid-19 Outbreak on Viral Vector Manufacturing Services Market
           5.1.1. Direct Impact on Production
           5.1.2. Supply Chain and Market Disruption
           5.1.3. Financial Impact on Firms and Financial Markets
       5.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
       5.3. Viral Vector Manufacturing Services Market: Pre V/S Post COVID-19
       5.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Viral Vector Manufacturing Services Market Size in 2020, by Scenario
       5.5. COVID-19: Micro and Macro Factor Analysis on Viral Vector Manufacturing Services Market

6 . GLOBAL VIRAL VECTOR MANUFACTURING SERVICES MARKET ANALYSIS BY PRODUCT
       6.1 Overview by Product
       6.2 Historical Data 2015-2018
       6.3 Global Viral Vector Manufacturing Services Market Analysis by Product
       6.4 Market Analysis of Retroviral Vectors by Regions
       6.6 Market Analysis of Adenoviral Vectors by Regions
       6.5 Market Analysis of Adeno-associated Viral Vectors by Regions
       6.7 Market Analysis of Other by Regions

7 . GLOBAL VIRAL VECTOR MANUFACTURING SERVICES MARKET ANALYSIS BY APPLICATION
       7.1 Overview by Application
       7.2 Historical Data 2015-2018
       7.3 Global Viral Vector Manufacturing Services Market Analysis by Application
       7.4 Market Analysis of Pharmaceutical and Biopharmaceutical Companies by Regions
       7.5 Market Analysis of Research Institutes by Regions

8 . GLOBAL VIRAL VECTOR MANUFACTURING SERVICES MARKET ANALYSIS BY GEOGRAPHY
       8.1. Regional Outlook
       8.2. Introduction
       8.3. North America
           8.3.1. Overview and Historic Data
           8.3.2. North America Viral Vector Manufacturing Services Market Estimate By Market Segment
           8.3.3. North America Viral Vector Manufacturing Services Market Estimate By Country
           8.3.4. United State
           8.3.5. Canada
           8.3.6. Mexico
       8.4. Europe
           8.4.1. Overview and Historic Data
           8.4.2. Europe Viral Vector Manufacturing Services Market Estimate by Market Segment
           8.4.3. Europe Viral Vector Manufacturing Services Market Estimate by Country
           8.4.4. United Kingdom
           8.4.5. France
           8.4.6. Germany
           8.4.7. Italy
           8.4.8. Russia
           8.4.9. Rest Of Europe
       8.5. Asia Pacific
           8.5.1. Overview and Historic Data
           8.5.2. Asia Pacific Viral Vector Manufacturing Services Market Estimate by Market Segment
           8.5.3. Asia Pacific Viral Vector Manufacturing Services Market Estimate by Country
           8.5.4. China
           8.5.5. India
           8.5.6. Japan
           8.5.7. South Korea
           8.5.8. Australia
           8.5.9. Rest Of Asia Pacific
       8.6. Latin America
           8.6.1. Overview and Historic Data
           8.6.2. Latin America Viral Vector Manufacturing Services Market Estimate by Market Segment
           8.6.3. Latin America Viral Vector Manufacturing Services Market Estimate by Country
           8.6.4. Brazil
           8.6.5. Argentina
           8.6.6. Peru
           8.6.7. Chile
           8.6.8. Rest of Latin America
       8.7. Middle East & Africa
           8.7.1. Overview and Historic Data
           8.7.2. Middle East & Africa Viral Vector Manufacturing Services Market Estimate by Market Segment
           8.7.3. Middle East & Africa Viral Vector Manufacturing Services Market Estimate by Country
           8.7.4. Saudi Arabia
           8.7.5. UAE
           8.7.6. Israel
           8.7.7. South Africa
           8.7.8. Rest Of Middle East And Africa

9 . COMPETITIVE LANDSCAPE OF THE VIRAL VECTOR MANUFACTURING SERVICES COMPANIES
       9.1. Viral Vector Manufacturing Services Market Competition
       9.2. Partnership/Collaboration/Agreement
       9.3. Merger And Acquisitions
       9.4. New Product Launch
       9.5. Other Developments

10 . COMPANY PROFILES OF VIRAL VECTOR MANUFACTURING SERVICES INDUSTRY
       10.1. Company Share Analysis
       10.2. Market Concentration Rate
       10.3. Novasep
           10.3.1. Company Overview
           10.3.2. Financials
           10.3.3. Products
           10.3.4. Recent Developments
       10.4. Spark Therapeutics
           10.4.1. Company Overview
           10.4.2. Financials
           10.4.3. Products
           10.4.4. Recent Developments
       10.5. Lonza Pharma & Biotech
           10.5.1. Company Overview
           10.5.2. Financials
           10.5.3. Products
           10.5.4. Recent Developments
       10.6. Takara Bio
           10.6.1. Company Overview
           10.6.2. Financials
           10.6.3. Products
           10.6.4. Recent Developments
       10.7. Sartorius
           10.7.1. Company Overview
           10.7.2. Financials
           10.7.3. Products
           10.7.4. Recent Developments
       10.8. ABL
           10.8.1. Company Overview
           10.8.2. Financials
           10.8.3. Products
           10.8.4. Recent Developments
       10.9. Inc.
           10.9.1. Company Overview
           10.9.2. Financials
           10.9.3. Products
           10.9.4. Recent Developments
       10.10. Fujifilm Diosynth Biotechnologies
           10.10.1. Company Overview
           10.10.2. Financials
           10.10.3. Products
           10.10.4. Recent Developments
       10.11. Cobra Biologics
           10.11.1. Company Overview
           10.11.2. Financials
           10.11.3. Products
           10.11.4. Recent Developments
       10.12. Sanofi
           10.12.1. Company Overview
           10.12.2. Financials
           10.12.3. Products
           10.12.4. Recent Developments
     10.13. Finvector
           10.13.1. Company Overview
           10.13.2. Financials
           10.13.3. Products
           10.13.4. Recent Developments
       10.14. uniQure
           10.14.1. Company Overview
           10.14.2. Financials
           10.14.3. Products
           10.14.4. Recent Developments

*Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

LIST OF FIGURES

Research Scope of Viral Vector Manufacturing Services Report
Market Research Process
Market Research Methodology
Global Viral Vector Manufacturing Services Market Size, by Region (2019)
Porters Five Forces Analysis
Market Attractiveness Analysis by Product
Market Attractiveness Analysis by Application
Market Attractiveness Analysis by Region
Value Chain Analysis
Global Viral Vector Manufacturing Services Market Analysis by Product
Global Viral Vector Manufacturing Services Market Analysis in Retroviral Vectors by Region
Global Viral Vector Manufacturing Services Market Analysis in Adenoviral Vectors by Region
Global Viral Vector Manufacturing Services Market Analysis in Adeno-associated Viral Vectors by Region
Global Viral Vector Manufacturing Services Market Analysis in Other by Region
Global Viral Vector Manufacturing Services Market Analysis by Application
Global Viral Vector Manufacturing Services Market Analysis in Pharmaceutical and Biopharmaceutical Companies by Region
Global Viral Vector Manufacturing Services Market Analysis in Research Institutes by Region
Global Viral Vector Manufacturing Services Market by Revenue
North America Viral Vector Manufacturing Services Market by Revenue
Europe Viral Vector Manufacturing Services Market by Revenue
Asia Pacific Viral Vector Manufacturing Services Market by Revenue
Latin America Viral Vector Manufacturing Services Market by Revenue
Middle East & Africa Viral Vector Manufacturing Services Market by Revenue
Recent Development in Viral Vector Manufacturing Services Industry
Company Market Share Analysis

* Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

Choose your Buying Option

Single User License: $ 3950.00

Upto 10 Users License: $ 4950.00

Enterprise License: $ 8600.00

Data Pack: $ 2100.00

Buy Now

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

Buy sections of this report
Buy country level reports
Request for historical data
Request discounts available for Start-Ups & Universities

Request for Special Pricing

Objectives of Study

Define and measure the global market
Volume or revenue forecast of the global market and its various sub-segments with respect to main geographies
Analyze and identify major market trends along with the factors driving or inhibiting the market growth
Study the company profiles of the major market players with their market share
Analyze competitive developments

Why Choose Us

Client First Policy

Excellent Quality

After Sales Support

24/7 Email Support

Clients

Testimonials

" Doing business with Value Market Research was – quick, easy and accurate. We got what we expected. The team was very helpful and processes were altered for our convenience. The whole process from understanding our niche requirements to delivery to after sales was excellent. "

Vincenzo Baydar – Head Planning, Leading Food Chain, US

" Excellent work!! Working with you has been easy and direct. Your flexibility to alter the report scope and timely delivery assisted me in delivering my project proposal on time. "

Mia Tang, Director - Business Strategy, Steel Industry, Germany

" This is our second purchase and we have been obliged by the service. We appreciate the efforts put by Value Market Research in terms of understanding our needs, expanding the scope of the study, delivery and handling after sales queries. "